356 related articles for article (PubMed ID: 19944886)
1. Management of schizophrenia with substance use disorders.
Lybrand J; Caroff S
Psychiatr Clin North Am; 2009 Dec; 32(4):821-33. PubMed ID: 19944886
[TBL] [Abstract][Full Text] [Related]
2. Substance abuse and the management of medication nonadherence in schizophrenia.
Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
[TBL] [Abstract][Full Text] [Related]
3. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
Green AI
J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
[TBL] [Abstract][Full Text] [Related]
4. Schizophrenia and comorbid substance use disorder: effects of antipsychotics.
Green AI
J Clin Psychiatry; 2005; 66 Suppl 6():21-6. PubMed ID: 16107180
[TBL] [Abstract][Full Text] [Related]
5. Substance abuse in schizophrenia: a review.
Buckley PF
J Clin Psychiatry; 1998; 59 Suppl 3():26-30. PubMed ID: 9541335
[TBL] [Abstract][Full Text] [Related]
6. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.
Potvin S; Stip E; Lipp O; Elie R; Mancini-Marië A; Demers MF; Roy MA; Bouchard RH; Gendron A
Curr Med Res Opin; 2006 Jul; 22(7):1277-85. PubMed ID: 16834826
[TBL] [Abstract][Full Text] [Related]
7. Management of comorbid bipolar disorder and substance abuse.
Vornik LA; Brown ES
J Clin Psychiatry; 2006; 67 Suppl 7():24-30. PubMed ID: 16961421
[TBL] [Abstract][Full Text] [Related]
8. [Compliance with treatment in schizophrenia and mood disorders].
Sorvaniemi M; Kampman O
Duodecim; 2000; 116(3):277-84. PubMed ID: 11764451
[No Abstract] [Full Text] [Related]
9. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
Volavka J
J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611
[TBL] [Abstract][Full Text] [Related]
10. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
[TBL] [Abstract][Full Text] [Related]
11. Treatment of dual diagnosis disorders.
Murthy P; Chand P
Curr Opin Psychiatry; 2012 May; 25(3):194-200. PubMed ID: 22395768
[TBL] [Abstract][Full Text] [Related]
12. Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study.
Swartz MS; Wagner HR; Swanson JW; Stroup TS; McEvoy JP; Canive JM; Miller DD; Reimherr F; McGee M; Khan A; Van Dorn R; Rosenheck RA; Lieberman JA
J Nerv Ment Dis; 2006 Mar; 194(3):164-72. PubMed ID: 16534433
[TBL] [Abstract][Full Text] [Related]
13. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
Potvin S; Stip E; Roy JY
Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
[TBL] [Abstract][Full Text] [Related]
14. [Motivational interviewing for patients with comorbid schizophrenia and substance abuse disorders: a review].
Bechdolf A; Pohlmann B; Geyer C; Ferber C; Klosterkötter J; Gouzoulis-Mayfrank E
Fortschr Neurol Psychiatr; 2005 Dec; 73(12):728-35. PubMed ID: 16355315
[TBL] [Abstract][Full Text] [Related]
15. Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder.
Brunette MF; Mueser KT
J Clin Psychiatry; 2006; 67 Suppl 7():10-7. PubMed ID: 16961419
[TBL] [Abstract][Full Text] [Related]
16. Substance abuse in clozapine-treated schizophrenic patients.
Sand PG; Soyka M
J Neuropsychiatry Clin Neurosci; 1997; 9(4):626-7. PubMed ID: 9447510
[No Abstract] [Full Text] [Related]
17. Pharmacotherapy of patients with schizophrenia and substance abuse.
Wobrock T; Soyka M
Expert Opin Pharmacother; 2009 Feb; 10(3):353-67. PubMed ID: 19191675
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
San L; Arranz B; Martinez-Raga J
Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
[TBL] [Abstract][Full Text] [Related]
19. Behavioral interventions for dual-diagnosis patients.
Goldsmith RJ; Garlapati V
Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
[TBL] [Abstract][Full Text] [Related]
20. Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia.
Buckley PF
J Subst Abuse Treat; 1998; 15(2):113-6. PubMed ID: 9561949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
